1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2015-2019 Global Lyme Disease Diagnostics Market: US, Europe, Japan--Emerging Opportunities and Business Strategies--Competitive Landscape, Supplier Shares, Country Volume and Sales Segment Forecasts

The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

     - Hospitals
     - Commercial/Private Labs
     -Physician Offices
     - Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Lyme disease tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 203 pages and 11 tables

The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

     - Hospitals
     - Commercial/Private Labs
     -Physician Offices
     - Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Lyme disease tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 203 pages and 11 tables

Table Of Contents

2015-2019 Global Lyme Disease Diagnostics Market: US, Europe, Japan--Emerging Opportunities and Business Strategies--Competitive Landscape, Supplier Shares, Country Volume and Sales Segment Forecasts
I. Introduction
II. LYME DISEASE Worldwide Market and Technology Overview
A. Background
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. France: Market Size, Growth and Major Suppliers'
Sales and Market Shares
IV. Germany: Test Volume and Diagnostics Sales Forecast
by Market Segment
V. Italy: Test Volume and Diagnostics Sales Forecast
by Market Segment
VI. Japan: Test Volume and Diagnostics Sales Forecast
by Market Segment
VII. Spain: Market Size, Growth and Major Suppliers'
Sales and Market Shares
VIII. UK: Test Volume and Diagnostics Sales Forecast
by Market Segment

IX. USA: Market Size, Growth and Major Suppliers'
Sales and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Elitech Group


- Eiken Chemical
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako


List of Tables
Major Companies Developing or Marketing Lyme Disease
Tests
France
Lyme Disease Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Lyme Disease Testing Market Diagnostics Sales
by Major Supplier
Germany
Lyme Disease Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Lyme Disease Test Volume and Diagnostics Sales Forecast
by Market Segment
Japan
Lyme Disease Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Lyme Disease Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Lyme Disease Testing Market Diagnostics Sales
by Major Supplier
U.K.
Lyme Disease Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Lyme Disease Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Lyme Disease Testing Market Diagnostics Sales
by Major Supplier

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.VPGMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.